Delivery Order SPE2DB20D3103-SPE2DB24FP8E8
Award Date
8/7/24
Potential Completion Date
8/8/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,703.36, is for the delivery of VISIPAQUE 320 MG/ML BOTTLE 100ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 7, 2025. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,128.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product, with a performance period ending on May 21, 2025. This delivery order contract is a firm fixed-price type and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,615.78 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 26, 2024 with a completion date of August 27, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA valued at up to $999,999,999 through December 2025...
This is a $1,687.64 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of VISIPAQUE 320 MG/ML infusion bottles, with a completion date of July 23, 2024. The contract was awarded on July 22, 2024, and is a firm fixed-price agreement. The award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,845.73 Firm Fixed Price Delivery Order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, to support military treatment facilities and programs. The contract has an ultimate completion date of August 15, 2024 and was awarded on August 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, valued at $1,335.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product, with a period of performance ending on May 12, 2025. The contract is a firm fixed-price arrangement, and there is no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award, valued at $1,650.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical product. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $1,098.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a firm fixed-price delivery order for VISIPAQUE 270 MG/ML BOTTLE 150ML, with a completion date of June 11, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,618.94 firm fixed-price contract is for the supply of VISIPAQUE 320 MG/ML infusion bottles. The contract has an ultimate completion date of December 4, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,219.10, is a Firm Fixed Price Delivery Order for VISIPAQUE 320 MG/ML INFUS BTL 150ML, a medical supply product. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...